BioSpace News Archive

The new $12 million Ending the Pandemic Threat: A Grand Challenge for Universal Influenza Vaccine Development from the Bill & Melinda Gates Foundation and Lucy and Larry Page is an important and necessary step toward finding a game-changing solution to end the threat of flu, according to experts at the Sabin Vaccine Institute (Sabin), a leading advocate for expanding vaccine access and uptake across the world.

Warriors and their guests gathered to hike the challenging Usery Mountain Wind Cave trail and learn how to dine out nutritionally during a recent Wounded Warrior Project® (WWP) event designed to promote physical wellness and mental health.

Kodiak Sciences Inc. announced that presentations on its research will be made at the Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, being held from April 29 - May 3 in Honolulu, Hawaii.

Dr. Tobias Moeller-Bertram will discuss successfully treating complex pain and reducing opioid dependency at the Vancouver Convention Center, on Saturday, April 28 at 4:45 p.m.

As the CDC and FDA continue their investigation into possible sources of a strain of E. coli O157:H7 linked to romaine.

Stellar Biotechnologies, Inc. is announcing a one-for-seven reverse share split of its common shares.

BTG plc highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California.

Utah life sciences companies, and BioUtah members, ProLung, Inc., and Rosivo Inc., were among ten innovative companies announced as winners in the 16th annual Utah Innovation Awards, presented by Stoel Rives, LLP, and the Utah Technology Council. Winners were honored during a special awards dinner, April 26, at the Hilton Salt Lake City Center.

Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. announced that the U.S. Federal Trade Commission (FTC) has cleared the Amneal and Impax business combination, subject to Amneal and Impax’s agreement to divest certain products.